The MANE group announced on 2 September 2026 the acquisition of Cvista, a US supplier of citrus essential oil fractions and natural essences based in Riverview, Florida. The transaction provides for the integration of the American company’s teams, industrial facilities and technological expertise. The Florida site will host a global centre of excellence dedicated to citrus and beverages.
Insight from the experts at Auris Finance, M&A and corporate finance advisory firm.
The world’s fifth-largest flavour and fragrance player, MANE remains an independent family-owned business. The group passed two billion euros in revenue in 2025, at 2.012 billion, up 6.5% on a constant currency and scope basis. Cvista is its third acquisition of the year, following Belgian biotechnology company ChemoSensoryx Biosciences and Dutch company Fromatech Ingredients. The sequence reflects a sustained pace of acquisitions, directed towards modestly sized targets carrying differentiating technologies.
A premium on technological expertise
Cvista operates across the entire value chain, from raw material sourcing to the precise fractionation of aromatic compounds. The company has developed expertise in the purification of trace-level compounds, enabling the isolation of molecules present in very small quantities, among them valencene, decanal and nootkatone. Its automated industrial facility combines distillation, extraction, resin treatment and molecular distillation, and serves around one hundred and thirty customers worldwide.
The target stands out neither for its volumes nor for its commercial network, but for the rarity of its separation expertise. Assets of this kind are negotiated on the basis of a technology premium, in a sector where the ability to produce high-purity natural ingredients determines access to the most demanding formulations.
A US base geared towards beverages
The Florida location brings the group closer to several strategic sourcing regions, a decisive consideration in an industry exposed to agricultural uncertainty and price volatility. The future centre is also intended to underpin the partnership concluded with Arzeda for the production and commercialisation of the ViaLeaf Reb M sweetener technology, in the functional and reduced-sugar beverage segments. Sugar reduction requires formulators to offset losses in taste perception with more precise aromatic profiles, which gives citrus fractionation heightened strategic value. For the managers of SMEs and mid-cap companies positioned in comparable industrial niches, this consolidation movement opens up real valuation prospects.
Our experts at your side
Auris Finance supports business leaders in their M&A and corporate finance transactions.
Are you considering a fundraising, an industrial partnership or a sale in the ingredients and flavours sector? Our teams are at your disposal to assist you.
